Loading...
Loading...
By Sofía Garduño - Thu, 03/12/2026 - 10:46
Biotech advances in mRNA, Mexico’s obesity strategy and rising AI use in health highlight this week’s key developments in public health.
Featured content
Mon, 01/05/2026 - 08:30
Scaling functional medicine in Mexico requires ecosystem models and precision health to fight chronic disease, writes Gustavo Rodríguez.
https://mexicobusiness.news/tag/biotechnology
More Health
By Deyanira Chiñas - Thu, 03/12/2026 - 08:00
Plan México and nearshoring can drive pharmaceutical and medical device manufacturing growth to strengthen healthcare supply, writes Deyanira Chiñas.
By Hector Barillas - Thu, 03/12/2026 - 07:30
DTC diagnostics and microbiome testing are disrupting Mexico’s lab market by empowering the mobile-first consumer, writes Héctor Barillas.
By Sofía Garduño - Tue, 03/10/2026 - 10:20
BioNTech founders will launch a new mRNA biotech company as the firm focuses on late-stage oncology trials and prepares for a leadership transition.
By Aura Moreno - Tue, 02/24/2026 - 08:13
Diagnostic delays and uneven access highlight structural gaps in Mexico’s rare disease care and policy framework.
By Oswaldo Bernal - Mon, 02/23/2026 - 08:30
Plan México and AI-driven clinical research leverage 'creative destruction' to transform national health. Oswaldo Bernal explains.
By Aura Moreno - Wed, 02/18/2026 - 11:18
Mexico confirms 9,000+ measles cases and expands vaccination, supply oversight and domestic vaccine production.
By Aura Moreno - Mon, 02/16/2026 - 16:15
Mexico seeks to reduce medicine prices, expand local vaccine production, and strengthen public health supply chains.
By Luis Alberto Velez - Wed, 01/28/2026 - 06:00
CRISPR-Cas9 enables precise gene editing in oncology, upgrading immune hardware to reprogram and finish cancer, writes Luis Velez.
By MBN Staff - Mon, 01/19/2026 - 08:46
Multicare and KalVista partner to expand access to the first oral on-demand treatment for hereditary angioedema (HAE) across Latin America.
